Extrawell Pharmaceutical Holdings Limited (HKG:0858)

Market Cap	211.65M +101.3%
Revenue (ttm)	52.65M -11.4%
Net Income	-338.02M
EPS	-0.14
Shares Out	2.55B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,660,000
Average Volume	1,342,000
Open	0.0810
Previous Close	0.0830
Day's Range	0.0780 - 0.0830
52-Week Range	0.0410 - 0.1490
Beta	-0.12
RSI	55.53
Earnings Date	Jun 26, 2026

About HKG:0858

Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, and sell of pharmaceutical products in the People’s Republic of China and Hong Kong. The company manufactures transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus infection and weak cellular immune system; Wisk for the treatment of II-III degree of radio-injury of skin, normal common burn, actinic dermatitis, various infectious ulcers, and oral ulcers, as well as for trauma and post operation wound he...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 161
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0858